2019
Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer
Willem H, Jooste V, Boussari O, Romain G, Bouvier A. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer. European Journal Of Cancer Prevention 2019, 28: 167-172. PMID: 29738323, DOI: 10.1097/cej.0000000000000450.Peer-Reviewed Original ResearchConceptsColorectal cancerMetachronous metastasesMetachronous groupNet survivalStage IV colorectal cancerStage IV patientsAge-standardized incidenceDiagnosis of metastasisProportion of cancersSynchronous groupSynchronous metastasesIV patientsCancer RegistryPrimary diagnosisColorectal adenocarcinomaEpidemiological studiesStage IIIStage IVRelevant cutoffsMetastasisStage IICancerFirst monthMonthsIncidenceTime-to-cure and cure proportion in solid cancers in France. A population based study
Romain G, Boussari O, Bossard N, Remontet L, Bouvier A, Mounier M, Iwaz J, Colonna M, Jooste V, Registries F. Time-to-cure and cure proportion in solid cancers in France. A population based study. Cancer Epidemiology 2019, 60: 93-101. PMID: 30933890, DOI: 10.1016/j.canep.2019.02.006.Peer-Reviewed Original ResearchConceptsTestis cancerCancer sitesThyroid cancerCure proportionFrench cancer registriesMost cancer sitesLarge national databaseHealthcare policy makersGynaecologic cancerYounger patientsCancer RegistryColorectal cancerSurvival cure modelUrinary tractCancer careDigestive cancersSolid cancersSkin melanomaSolid tumorsSmall intestineCancerPatientsNational databaseBreastCure
2018
A new approach to estimate time-to-cure from cancer registries data
Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier A, Binquet C, Colonna M, Jooste V. A new approach to estimate time-to-cure from cancer registries data. Cancer Epidemiology 2018, 53: 72-80. PMID: 29414635, DOI: 10.1016/j.canep.2018.01.013.Peer-Reviewed Original ResearchConceptsPopulation-based cancer dataFlexible parametric cure modelsThyroid cancer patientsCancer registry dataParametric cure modelsCancer RegistryColorectal cancerCancer patientsPancreatic cancerCancer sitesBreast cancerRegistry dataCure modelAge groupsCancerCureDiagnosisSurvival frameworkCure fractionPatientsHealth insurance premiumsFrench networkSurvival time distributionYears